Advertisement
Skip to Content

CytoDyn Inc CYDY Stock Quote

| Rating as of

PINX: CYDY

Last close prices updated as of Jan 30, 2023, 4:00 PM EST | USD
  • Last Close 0.2889
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.27  –  0.30
  • Year Range 0.15  –  1.26
  • Market Cap 236.8136 Mil
  • Volume / Avg 2.1 Mil /  2.2 Mil
  • Price / Sales 761.84
  • Price / Book 1,066.03
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CYDY

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CYDY

Company Profile CYDY

Business Description

CytoDyn Inc is a US-based clinical-stage biotechnology company which focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The lead product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.

Contact
1111 Main Street, Suite 660
Vancouver, WA, 98660
Industry Biotechnology
Employees 23

FAQs for CytoDyn Inc Stock

No. CYDY does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CYDY’s market cap is 236.81 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CYDY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CYDY’s historical performance against its industry peers and the overall market.